You Searched For "Johnson Johnson" and got 20 results
Sort By:
1 min read
Johnson & Johnson plans to buy back shares up to $10 bln
The company said on Tuesday it had about 2.77 billion shares of common stock outstanding as of Sept…
2 mins read
The US recommended suspending the Johnson & Johnson vaccine just as Europe was about to start using it
US health agencies temporarily suspended the use of the vaccine just as 55 million doses started be…
Marianne Guenot
1 min read
Single shot Covid-19 vaccine shows 66% efficacy overall: Johnson & Johnson
Johnson & Johnson on Friday said its single-shot vaccine has been found to be 66 per cent effective…
1 min read
Johnson & Johnson beats earnings expectations
In the earnings release, CEO Alex Gorsky said: "Our solid sales and earnings results in the quarter…
Akin Oyedele
1 min read
The CEO of the biotech firm that ruined Johnson & Johnson vaccine doses told CNBC 'it was one batch'
Kramer said there wasn't cross-contamination of ingredients, but that doses were pulled because of …
Azmi Haroun
2 mins read
Johnson & Johnson falls despite earnings beat after pausing COVID-19 vaccine trial over 'unexplained illness'
Johnson & Johnson's COVID-19 vaccine is being developed by its Janssen pharmaceutical unit and is i…
Matthew Fox
3 mins read
Millions of Johnson & Johnson COVID-19 vaccines are set to expire this month, and states are scrambling to use up their stockpiles or send them abroad
US states are racing to use up stocks of the Johnson & Johnson vaccine, or send them elsewhere. Pub…
Grace Dean
1 min read
Johnson & Johnson is delaying the rollout of its COVID-19 vaccine in Europe after US officials recommended pausing its use
The US CDC advised health officials to stop giving the shots out of an "abundance of caution" becau…
Paul Squire
2 mins read
Momenta Pharmaceuticals spikes 69% after agreeing to $6.5 billion Johnson & Johnson takeover
The deal values Momenta at $52.50 per share, a 70.4% premium to its Wednesday close. The deal is ex…
Ben Winck
1 min read
Johnson & Johnson is buying $10 billion worth of itself
Ahead of the release, the healthcare and consumer products giant announced a $10 billion share buyb…
Akin Oyedele
6 mins read
Johnson & Johnson Issues Weak Earnings Guidance For 2013
NEW BRUNSWICK, N.J., Jan. 22, 2013 /PRNewswire/ -- Johnson & Johnson (JNJ) today announced sale…
Matthew Boesler
1 min read
Johnson & Johnson is still getting whacked by the strong dollar
CEO Alex Grosky said in a release, "The company delivered strong underlying growth in the first qua…
Akin Oyedele
1 min read
Trump and Biden officials knew about quality-control problems at the Baltimore facility that ruined 15 million COVID-19 vaccine doses, report says
The Emergent BioSolutions plant unknowingly cross-contaminated some 15 million doses of the J&J vac…
Sinéad Baker
2 mins read
Johnson & Johnson's net earnings dropped 14% in the first-quarter
The company has come under pressure in recent months after a Reuters investigation in mid-December …
Rebecca Ungarino
1 min read
Republicans in Pennsylvania placed robocalls that appeared to be from 'Johnson & Johnson'
The Bucks County Republican Party blamed the incident on a third-party vendor and an "unintended te…
Charles Davis
1 min read
Buffett's Berkshire Buys More GM, Sells Johnson & Johnson
According to StreetInsider, Warren Buffett's Omaha-based portfolio lowered its stake in Johnson &am…
Rob Wile
1 min read
Johnson & Johnson's Fourth Quarter Sales Got Whacked By Currencies
Overall, J&J posted adjusted profit of $1.27 per share in the fourth quarter on sales that decl…
Akin Oyedele
1 min read
Johnson & Johnson is sliding after guidance comes up short
The pharmaceutical giant reported adjusted earnings of $1.97 a share in the fourth quarter - $0.02 …
Ethel Jiang
2 mins read
The factory that had to toss J&J coronavirus vaccines has made 150 million doses. Regulators haven't let any reach the public.
The factory hasn't been certified by regulators to distribute the doses to the public, the New York…
Kelly McLaughlin
1 min read
Manufacturer that ruined 15 million Johnson & Johnson vaccine doses once got a $163 million federal contract to improve its facility: NYT
The federal government first invested in the Emergent BioSolutions more than eight years ago, the N…